Gsa Capital Partners LLP Hutchmed (China) LTD Transaction History

Gsa Capital Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$23.09 - $37.69 $846,825 - $1.38 Million	-36,675 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$26.55 - $34.38 $4.93 Million - $6.38 Million	-185,670 Reduced 83.51%	36,675 $1.18 Million
Q2 2018 Aug 09, 2018	BUY	$27.79 - $34.49 $585,729 - $726,945	21,077 Added 10.47%	222,345 $6.7 Million
Q1 2018 May 11, 2018	BUY	$28.87 - $41.13 $3.19 Million - $4.55 Million	110,668 Added 122.15%	201,268 $5.95 Million
Q4 2017 Feb 14, 2018	BUY	$27.41 - $39.42 $2.48 Million - $3.57 Million	90,600	90,600 $3.57 Million

6.88M

6.2K

1.1K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $2.5B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.